159 related articles for article (PubMed ID: 6455095)
1. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
Becker LE; Bergstresser PR; Whiting DA; Clendenning WE; Dobson RL; Jordan WP; Abell E; LeZotte LA; Pochi PE; Shupack JL; Sigafoes RB; Stoughton RB; Voorhees JJ
Arch Dermatol; 1981 Aug; 117(8):482-5. PubMed ID: 6455095
[TBL] [Abstract][Full Text] [Related]
2. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
Kuhlman DS; Callen JP
Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
[TBL] [Abstract][Full Text] [Related]
3. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
[TBL] [Abstract][Full Text] [Related]
4. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
Braathen LR
Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
[TBL] [Abstract][Full Text] [Related]
5. Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation.
McKenzie MW; Beck DC; Popovich NG
Arch Dermatol; 1981 Oct; 117(10):630-4. PubMed ID: 6456699
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
Bran EL; Robledo Aguilar A
Med Cutan Ibero Lat Am; 1986; 14(6):433-42. PubMed ID: 2951570
[TBL] [Abstract][Full Text] [Related]
7. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
8. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
Goltz RW; Coryell GM; Schnieders JR; Neidert GL
Cutis; 1985 Sep; 36(3):265-8. PubMed ID: 2932307
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
10. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
Schmidt JB; Neumann R; Fanta D; Raab W
Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
[TBL] [Abstract][Full Text] [Related]
11. Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial.
Gratton D; Raymond GP; Guertin-Larochelle S; Maddin SW; Leneck CM; Warner J; Collins JP; Gaudreau P; Bendl BJ
J Am Acad Dermatol; 1982 Jul; 7(1):50-3. PubMed ID: 6213682
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
14. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
Katsambas A; Towarky AA; Stratigos J
Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
Thomas DR; Raimer S; Smith EB
Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
[TBL] [Abstract][Full Text] [Related]
17. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
[TBL] [Abstract][Full Text] [Related]
18. [Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne].
Perez M; Aspiolea F; De Moragas JM
Med Cutan Ibero Lat Am; 1987; 15(3):173-7. PubMed ID: 2959827
[No Abstract] [Full Text] [Related]
19. Clindamycin vs placebo as adjunctive therapy in moderately severe acne.
Christian GL; Krueger GG
Arch Dermatol; 1975 Aug; 111(8):997-1000. PubMed ID: 134670
[TBL] [Abstract][Full Text] [Related]
20. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris.
Borglund E; Hägermark O; Nord CE
Scand J Infect Dis Suppl; 1984; 43():76-81. PubMed ID: 6242074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
